SZN-1326

N/A

Report date: 2022/10/20 11:23:41

Base Information

Drug NameSZN-1326

Drug Alias NameSZN-1326

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionWnt signalling pathway stimulantsAnti-FZD5Anti-FZD8 +[4]

TargetsFrizzled-5Frizzled-8Low-density lipoprotein receptor-related protein 6

Therapy Area/IndicationsInflammatory Bowel Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesSurrozen Inc

China Registration ClassN/A

Develop Information

Active CompaniesSurrozen Inc

Inactive CompaniesN/A

Active IndicationsInflammatory Bowel Diseases

Inactive IndicationsN/A

Other Information

ATC CodeN/A